A456190 Stock Overview
Curachem Inc. provides services in custom carbon-14 radio labeling, stable isotope labeling, and medical chemistry and process development.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Curachem Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩21,000.00 |
| 52 Week High | ₩20,150.00 |
| 52 Week Low | ₩17,920.00 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 20.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| A456190 | KR Life Sciences | KR Market | |
|---|---|---|---|
| 7D | 0% | 3.1% | 3.4% |
| 1Y | n/a | 2.9% | 7.1% |
Return vs Industry: Insufficient data to determine how A456190 performed against the KR Life Sciences industry.
Return vs Market: Insufficient data to determine how A456190 performed against the KR Market.
Price Volatility
| A456190 volatility | |
|---|---|
| A456190 Average Weekly Movement | n/a |
| Life Sciences Industry Average Movement | 7.4% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 11.8% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A456190 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine A456190's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | n/a | Sook-Jung Shin | www.curachem.com |
Curachem Inc. provides services in custom carbon-14 radio labeling, stable isotope labeling, and medical chemistry and process development. Its custom carbon-14 radio labeling services include designing new synthetic routes for labeling at specified positions, multi-step and label synthesis, carbon-14 manifold for radio labeling with volatile radio chemicals, and stable isotope labeling synthesis. The company's medical chemistry and process development services comprise analyzing hit compounds, designing, and synthesizing focused libraries based on hits, analyzing SAR propose optimization plans, and molecular modeling and quantitative SAR for data analysis and drug design.
Curachem Inc. Fundamentals Summary
| A456190 fundamental statistics | |
|---|---|
| Market cap | ₩36.84b |
| Earnings (TTM) | ₩0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs A456190 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A456190 income statement (TTM) | |
|---|---|
| Revenue | ₩0 |
| Cost of Revenue | ₩0 |
| Gross Profit | ₩0 |
| Other Expenses | ₩0 |
| Earnings | ₩0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did A456190 perform over the long term?
See historical performance and comparison